Most effective place for a Wegovy shot: making the right choice for you

Why the site decision matters more than people expect

Most people, when they start Wegovy, focus on the pen, the dose and the day of the week. The injection site is almost an afterthought. That's understandable, but it's worth revisiting, because poor site selection is one of the more common reasons people experience more discomfort or more unpredictable absorption than they should.

Semaglutide is injected subcutaneously, into the fatty tissue just beneath the skin, not into muscle. Each of the three approved sites carries enough subcutaneous tissue in most adults to make that possible. The problem isn't usually the site itself; it's injecting repeatedly into exactly the same small patch of skin. Over time, that causes lipohypertrophy: a hardening or lumpy thickening of the tissue that slows how the medicine is taken up. You can read more about choosing the best site for your Wegovy shot in detail, including what lipohypertrophy looks like and how to avoid it.

The practical upshot: rotate. Not just between sites, but within them. Think of the abdomen as a clock face and move around it. Keep each new spot at least 2–3 cm away from the last. That simple discipline protects your skin and keeps absorption consistent across the weeks of your treatment.

Abdomen, thigh or upper arm: what suits which situation

The abdomen (specifically the area at least a few centimetres away from the navel) is the most widely used site, and for most people it's the easiest one to manage alone. The skin there is reliably accessible, easy to pinch if needed, and simple to inspect before you inject. If you're self-injecting at home on a weekday morning before the school run, the abdomen is usually the path of least resistance.

The front of the thigh is the next most common choice, and it has one clear advantage: it's entirely self-manageable, even for people who find reaching round to the abdomen awkward. It's also easy to visualise, which helps when you're checking for any skin changes. Some people find the thigh slightly more uncomfortable, particularly at lower body-fat levels where there's less subcutaneous tissue; if that's the case, the abdomen is usually more forgiving.

The outer upper arm is the site that tends to need a second pair of hands. Injecting there yourself, accurately and at the right depth, is possible but technically harder. If someone at home can help with your weekly dose, the upper arm becomes a genuinely useful rotation option, particularly if you're alternating with the thigh to spread the load. For more on the practical differences, the best place for Wegovy guide walks through each site with the same level of detail.

What the evidence actually says about site differences

The licensed smaglutide prescribing information does not rank the three sites by efficacy, and that's telling. The clinical trials supporting Wegovy's approval, including the STEP 1 study published in the New England Journal of Medicine, did not demonstrate a meaningful absorption difference between abdomen, thigh and upper arm when technique is sound.

What does shift absorption is technique. Injecting into scar tissue, recently bruised skin, or areas affected by lipohypertrophy reduces uptake. Cold medication matters too: a pen taken straight from the back of the fridge and injected immediately can cause more stinging and potentially slower local absorption. Letting it reach room temperature for around thirty minutes first is a commonly cited practical tip, though your Patient Information Leaflet and prescriber's guidance take precedence on timing.

Results from Wegovy's clinical programme (average body-weight reductions around 15% over 68 weeks in the STEP 1 trial) were achieved across all three sites, with technique and consistency as the controlling variables, not site selection alone. If you're weighing up how Wegovy performs against other semaglutide options, our guide to what is more effective, Ozempic or Wegovy, puts the trial data side by side so you can see the differences clearly. If you're comparing Wegovy's trial outcomes against other treatments, the Wegovy versus placebo data gives a fuller picture of the STEP programme's findings.

Practical decisions your prescriber will help you make

Choosing a site isn't a one-time decision. As your body changes during treatment, your preferred site may change with it. Some people start on the abdomen and shift to the thigh after several months; others find the upper arm becomes easier as they get more confident with the pen. Your prescriber is the right person to discuss this with, particularly if you notice skin changes, if a site becomes consistently uncomfortable, or if you're unsure about your technique.

It's also worth knowing that site rotation applies separately to Wegovy and any other injectables you use. If you're on insulin or another subcutaneous medicine, make sure you're not overloading a single area. Your pharmacist or prescriber can map out a rotation plan that accounts for everything.

Wegovy is a prescription-only medicine, and the injection guidance in your Patient Information Leaflet is specific to the formulation you've been prescribed. The full Wegovy overview covers what the treatment involves from the first dose onwards. If you have questions about cost and what's included in a private prescription, the Wegovy pricing guide sets out what the UK private market looks like honestly.

Our prescribers at nume review every consultation personally. If you'd like to discuss which site suits your situation, or you're ready to begin treatment, speak to our prescribers through a free consultation.